227 related articles for article (PubMed ID: 22773801)
1. Acute lymphoblastic leukemia.
Alvarnas JC; Brown PA; Aoun P; Ballen KK; Bellam N; Blum W; Boyer MW; Carraway HE; Coccia PF; Coutre SE; Cultrera J; Damon LE; DeAngelo DJ; Douer D; Frangoul H; Frankfurt O; Goorha S; Millenson MM; O'Brien S; Petersdorf SH; Rao AV; Terezakis S; Uy G; Wetzler M; Zelenetz AD; Naganuma M; Gregory KM;
J Natl Compr Canc Netw; 2012 Jul; 10(7):858-914. PubMed ID: 22773801
[TBL] [Abstract][Full Text] [Related]
2. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Brown PA; Shah B; Advani A; Aoun P; Boyer MW; Burke PW; DeAngelo DJ; Dinner S; Fathi AT; Gauthier J; Jain N; Kirby S; Liedtke M; Litzow M; Logan A; Luger S; Maness LJ; Massaro S; Mattison RJ; May W; Oluwole O; Park J; Przespolewski A; Rangaraju S; Rubnitz JE; Uy GL; Vusirikala M; Wieduwilt M; Lynn B; Berardi RA; Freedman-Cass DA; Campbell M
J Natl Compr Canc Netw; 2021 Sep; 19(9):1079-1109. PubMed ID: 34551384
[TBL] [Abstract][Full Text] [Related]
3. Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.
Burkart M; Dinner S
Blood Rev; 2024 Jul; 66():101208. PubMed ID: 38734488
[TBL] [Abstract][Full Text] [Related]
4. Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?
Short NJ; Kantarjian H; Jabbour E
Expert Rev Hematol; 2024 Jun; 17(6):189-191. PubMed ID: 38726703
[No Abstract] [Full Text] [Related]
5. Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
Schultz KR; Devidas M; Bowman WP; Aledo A; Slayton WB; Sather H; Zheng HW; Davies SM; Gaynon PS; Trigg M; Rutledge R; Jorstad D; Carroll AJ; Heerema N; Winick N; Borowitz MJ; Hunger SP; Carroll WL; Camitta B;
Leukemia; 2014 Apr; 28(4):964-7. PubMed ID: 24434862
[No Abstract] [Full Text] [Related]
6. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
Blood; 2024 May; 143(19):1903-1930. PubMed ID: 38306595
[TBL] [Abstract][Full Text] [Related]
7. [Minimal residual disease in adults with Philadelphia chromosome negative acute lymphoblastic leukemia in high-risk].
Li ZR; Zhao T; Liu YR; Wang YZ; Xu LP; Zhang XH; Wang Y; Jiang H; Chen YY; Chen H; Han W; Yan CH; Wang J; Jia JS; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):554-560. PubMed ID: 32397017
[No Abstract] [Full Text] [Related]
8. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
Radich JP
Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
[TBL] [Abstract][Full Text] [Related]
9. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
Forghieri F; Luppi M; Potenza L
Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia.
Chang J; Douer D; Aldoss I; Vahdani G; Jeong AR; Ghaznavi Z; Zhang S; Yaghmour G; Lee KJ; Weissman A; Akhtari M
Cancer Med; 2019 Jun; 8(6):2832-2839. PubMed ID: 31016870
[TBL] [Abstract][Full Text] [Related]
11. Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hara R; Onizuka M; Kikkawa E; Shiraiwa S; Harada K; Aoyama Y; Ogiya D; Toyosaki M; Suzuki R; Machida S; Ohmachi K; Ogawa Y; Kawada H; Matsushita H; Ando K
Ann Hematol; 2021 Oct; 100(10):2479-2486. PubMed ID: 34247299
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
Faderl S; Garcia-Manero G; Thomas DA; Kantarjian HM
Rev Clin Exp Hematol; 2002 Jun; 6(2):142-60; discussion 200-2. PubMed ID: 12196213
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Brown P; Inaba H; Annesley C; Beck J; Colace S; Dallas M; DeSantes K; Kelly K; Kitko C; Lacayo N; Larrier N; Maese L; Mahadeo K; Nanda R; Nardi V; Rodriguez V; Rossoff J; Schuettpelz L; Silverman L; Sun J; Sun W; Teachey D; Wong V; Yanik G; Johnson-Chilla A; Ogba N
J Natl Compr Canc Netw; 2020 Jan; 18(1):81-112. PubMed ID: 31910389
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
Czyz A; Lewandowski K; Kroll R; Komarnicki M
Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
[TBL] [Abstract][Full Text] [Related]
16. Clinical updates in adult acute lymphoblastic leukemia.
Al Ustwani O; Gupta N; Bakhribah H; Griffiths E; Wang E; Wetzler M
Crit Rev Oncol Hematol; 2016 Mar; 99():189-99. PubMed ID: 26777876
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lestingi TM; Hooberman AL
Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease in Philadelphia-positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing.
Saliba AN; Foà R
Am J Hematol; 2023 Aug; 98(8):1168-1170. PubMed ID: 37314420
[No Abstract] [Full Text] [Related]
20. How we approach Philadelphia chromosome-positive acute lymphoblastic leukemia in children and young adults.
Slayton WB; Schultz KR; Silverman LB; Hunger SP
Pediatr Blood Cancer; 2020 Oct; 67(10):e28543. PubMed ID: 32779849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
